In February 2025, a medical team at UCSF delivered the first personalized CRISPR therapy to an infant with CPS1 deficiency, a rare metabolic disorder that prevents the body from breaking down ammonia. The treatment was designed specifically for that child's genetic mutation, built from scratch as a one-time intervention outside any clinical trial. For families navigating rare pediatric diagnoses, that news raises the question everyone asks: does this apply to my child? The short answer is that most children with rare disorders won't qualify for personalized CRISPR therapy in the next few years. But the infrastructure being built right now, including the research centers, clinical trials, and specialized expertise at major children's hospitals, will determine which conditions move from "in development" to "available" over the next decade. Knowing where that infrastructure exists and what questions to ask your care team matters more than following every breakthrough announcement. What CRISPR Does and What It Doesn't Fix. CRISPR is a gene editing tool. It cuts DNA at a specific location and either removes a faulty segment, inserts a corrected one, or turns a gene on or off. When it works, it addresses the genetic cause of a disease rather than managing symptoms. That precision is what makes it powerful for rare disorders. Many of these conditions are caused by a single mutation in a known gene. If you can fix that mutation, you can stop the disease progression. But CRISPR doesn't work for every rare disorder. It's most effective when the genetic...

The first personalized CRISPR therapy was delivered to an infant in February 2025. What this means for your child's eligibility.

CRISPR Gene Therapy for Rare Pediatric Disorders: What Families Need to Know

In February 2025, a medical team at UCSF delivered the first personalized CRISPR therapy to an infant with CPS1 deficiency, a rare metabolic disorder that prevents the body from breaking down ammonia. The treatment was designed specifically for that child's genetic mutation, built from scratch as a one-time intervention outside any clinical trial. For families navigating rare pediatric diagnoses, that news raises the question everyone asks: does this apply to my child? The short answer is that most children with rare disorders won't qualify for personalized CRISPR therapy in the next few years. But the infrastructure being built right now, including the research centers, clinical trials, and specialized expertise at major children's hospitals, will determine which conditions move from "in development" to "available" over the next decade. Knowing where that infrastructure exists and what questions to ask your care team matters more than following every breakthrough announcement. What CRISPR Does and What It Doesn't Fix. CRISPR is a gene editing tool. It cuts DNA at a specific location and either removes a faulty segment, inserts a corrected one, or turns a gene on or off. When it works, it addresses the genetic cause of a disease rather than managing symptoms. That precision is what makes it powerful for rare disorders. Many of these conditions are caused by a single mutation in a known gene. If you can fix that mutation, you can stop the disease progression. But CRISPR doesn't work for every rare disorder. It's most effective when the genetic...

Your child has a rare disorder. The school district has never served a student with this condition. When you request an IEP evaluation, staff tell you they don't know how to write accommodations for something they've never seen before. This is not a valid reason to delay or deny services. IDEA (the Individuals with Disabilities Education Act) protects all children with disabilities that impact their education, regardless of whether the diagnosis has a name, whether staff have prior experience with it, or whether anyone at the district knows what it is. Eligibility is based on educational impact, not diagnosis recognition. Why "We've Never Seen This Before" Doesn't Matter. School districts evaluate children based on how a disability affects their ability to access education. They don't diagnose medical conditions. They assess educational need. A child with a rare metabolic disorder who fatigues after 30 minutes of cognitive work qualifies for accommodations based on that functional limitation. The district doesn't need to understand the metabolic pathway. They need to understand that the child can't sustain attention through a 90-minute block without support. IDEA's 13 disability categories include "Other Health Impairment," which covers conditions that limit strength, vitality, or alertness due to chronic or acute health problems. This category exists specifically for conditions that don't fit neatly into other buckets. Rare disorders with educational impact qualify here. If your child's condition is so rare that it's undiagnosed or doesn't have an established name, that doesn't change anything. The evaluation measures functional limitations in...

When your child's condition is so rare that school staff have never seen it, IDEA still protects them. Here's how to advocate.

IEP Advocacy for Children with Rare Disorders: When No One Has Done This Before

Your child has a rare disorder. The school district has never served a student with this condition. When you request an IEP evaluation, staff tell you they don't know how to write accommodations for something they've never seen before. This is not a valid reason to delay or deny services. IDEA (the Individuals with Disabilities Education Act) protects all children with disabilities that impact their education, regardless of whether the diagnosis has a name, whether staff have prior experience with it, or whether anyone at the district knows what it is. Eligibility is based on educational impact, not diagnosis recognition. Why "We've Never Seen This Before" Doesn't Matter. School districts evaluate children based on how a disability affects their ability to access education. They don't diagnose medical conditions. They assess educational need. A child with a rare metabolic disorder who fatigues after 30 minutes of cognitive work qualifies for accommodations based on that functional limitation. The district doesn't need to understand the metabolic pathway. They need to understand that the child can't sustain attention through a 90-minute block without support. IDEA's 13 disability categories include "Other Health Impairment," which covers conditions that limit strength, vitality, or alertness due to chronic or acute health problems. This category exists specifically for conditions that don't fit neatly into other buckets. Rare disorders with educational impact qualify here. If your child's condition is so rare that it's undiagnosed or doesn't have an established name, that doesn't change anything. The evaluation measures functional limitations in...

When your child's condition is so rare that school staff have never seen it, IDEA still protects them. Here's how to advocate.

The average US tariff rate climbed to roughly 17% in 2025 — the highest in three decades, up from less than 3% before. Pharmaceutical tariffs proposed by mid-to-late 2026 could reach 200%. While the Supreme Court struck down certain IEEPA-based tariffs on February 20, 2026, tariffs imposed under other statutory authorities remain in effect. Goldman Sachs estimates that consumers will absorb roughly 70% of tariff costs in 2026 as inventories deplete, translating to $592 billion in higher prices for US households. For families navigating disability, that translates directly to wheelchairs, walkers, adaptive equipment, AAC devices, and specialty medications. Most durable medical equipment is manufactured in China and Southeast Asia. AAC hardware comes from abroad. Specialty medications for rare diseases often depend on foreign active pharmaceutical ingredients. When tariff chains hit those supply lines, the end price rises — and families already fighting insurance denials face a new barrier. What's Getting More Expensive. Durable medical equipment: Wheelchairs, walkers, patient lifts, adaptive seating, positioning devices. Manufacturing is concentrated overseas; tariff costs pass through distributors and land on retail and insurance reimbursement rates. AAC devices: Speech-generating devices, communication tablets, eye-gaze hardware. Most components are manufactured abroad. Even software-only solutions run on hardware subject to tariffs. Pharmaceutical products: Specialty medications for rare genetic conditions, seizure disorders, metabolic diseases. Many rely on imported active ingredients or are manufactured entirely outside the US. Proposed tariffs up to 200% could make some medications financially inaccessible. Replacement parts and repairs: Wheelchair wheels, joystick controllers,...

Tariffs Are Raising the Cost of Wheelchairs, AAC Devices, and Medications — What Families Can Do

The average US tariff rate climbed to roughly 17% in 2025 — the highest in three decades, up from less than 3% before. Pharmaceutical tariffs proposed by mid-to-late 2026 could reach 200%. While the Supreme Court struck down certain IEEPA-based tariffs on February 20, 2026, tariffs imposed under other statutory authorities remain in effect. Goldman Sachs estimates that consumers will absorb roughly 70% of tariff costs in 2026 as inventories deplete, translating to $592 billion in higher prices for US households. For families navigating disability, that translates directly to wheelchairs, walkers, adaptive equipment, AAC devices, and specialty medications. Most durable medical equipment is manufactured in China and Southeast Asia. AAC hardware comes from abroad. Specialty medications for rare diseases often depend on foreign active pharmaceutical ingredients. When tariff chains hit those supply lines, the end price rises — and families already fighting insurance denials face a new barrier. What's Getting More Expensive.  Durable medical equipment: Wheelchairs, walkers, patient lifts, adaptive seating, positioning devices. Manufacturing is concentrated overseas; tariff costs pass through distributors and land on retail and insurance reimbursement rates.  AAC devices: Speech-generating devices, communication tablets, eye-gaze hardware. Most components are manufactured abroad. Even software-only solutions run on hardware subject to tariffs.  Pharmaceutical products: Specialty medications for rare genetic conditions, seizure disorders, metabolic diseases. Many rely on imported active ingredients or are manufactured entirely outside the US. Proposed tariffs up to 200% could make some medications financially inaccessible.  Replacement parts and repairs: Wheelchair wheels, joystick controllers,...

In a study released April 9, 2012 by Pediatrics, researchers looked at the possible link between metabolic conditions and autism. While there were more cases of autism amongst mothers with metabolic conditions, such as diabetes, obesity, and hypertension, metabolic conditions do not cause autism. While the research is interesting, most experts agree that this research does not account for the startling increase in the number of cases of autism. The study found that women with diabetes or hypertension were 1.61 times more likely to have a child with an autism spectrum disorder, and they were also 2.35 times more likely to have a child with developmental disabilities than women without these metabolic conditions. With the CDC's announcement in March that 1 in 88 children have autism, people are looking for answers. In the study published April 9, researchers led by UC Davis epidemiologist Paula Krakowiak investigated 1,004 California children between the ages of 2 and 5. 512 of these children had an autism spectrum disorder, 172 had developmental disabilities, and 312 of the children showed typical development. There was not a statistically significant relationship between autism and diabetes, but there was a slight link between diabetes and developmental disabilities. While most of the media is now pointing to obesity as a cause of autism, remember that this study looked at only 1,000 children, and it only proposes a link between the two conditions, and not a causal relationship....

Study suggests link between maternal obesity, diabetes, hypertension and higher autism, developmental disability risk in children.

Obesity Linked to Autism

 In a study released April 9, 2012 by Pediatrics, researchers looked at the possible link between metabolic conditions and autism. While there were more cases of autism amongst mothers with metabolic conditions, such as diabetes, obesity, and hypertension, metabolic conditions do not cause autism.    While the research is interesting, most experts agree that this research does not account for the startling increase in the number of cases of autism.   The study found that women with diabetes or hypertension were 1.61 times more likely to have a child with an autism spectrum disorder, and they were also 2.35 times more likely to have a child with developmental disabilities than women without these metabolic conditions.   With the CDC's announcement in March that 1 in 88 children have autism, people are looking for answers. In the study published April 9, researchers led by UC Davis epidemiologist Paula Krakowiak investigated 1,004 California children between the ages of 2 and 5. 512 of these children had an autism spectrum disorder, 172 had developmental disabilities, and 312 of the children showed typical development.   There was not a statistically significant relationship between autism and diabetes, but there was a slight link between diabetes and developmental disabilities.   While most of the media is now pointing to obesity as a cause of autism, remember that this study looked at only 1,000 children, and it only proposes a link between the two conditions, and not a causal relationship....

Yale researchers announced on April 2, 2026 that they've identified several FDA-approved drug candidates that reverse disrupted behaviors in zebrafish carrying mutations linked to autism. The team screened 774 drugs against zebrafish with mutations in two autism risk genes (SCN2A and DYRK1A) and published their findings in the Proceedings of the National Academy of Sciences. What the Study Found. The Yale team created a database of 520 FDA-approved drugs and their effects on basic behaviors in zebrafish larvae. They then tested how these drugs affected zebrafish carrying mutations in SCN2A and DYRK1A, two genes strongly associated with autism spectrum disorder in humans. Levocarnitine emerged as a top candidate. This compound, which transports fatty acids into mitochondria for energy production, reversed dysregulated sleep and sensory processing behaviors in zebrafish with both gene mutations. According to the study, levocarnitine also corrected disrupted lipid metabolism and abnormal brain activity patterns in the zebrafish models. The researchers identified additional drug candidates specific to each gene mutation. Estropipate, an estrogen receptor agonist, suppressed behaviors linked to SCN2A mutations. Paclitaxel, a microtubule inhibitor already used in cancer treatment, showed promise for DYRK1A-related behaviors. Why This Matters for Families. Drug development timelines for autism treatments typically span decades. By screening FDA-approved drugs that have already cleared safety trials, researchers can potentially accelerate the path to clinical testing in humans. If a drug is already approved for another condition, doctors may prescribe it off-label while formal autism trials proceed. The focus on specific genetic mutations means families who...

Yale scientists screened 774 FDA-approved drugs in zebrafish with autism gene mutations, identifying levocarnitine and other candidates.

Yale Researchers Used Zebrafish to Find Drug Candidates That Could Help Children with Autism

Yale researchers announced on April 2, 2026 that they've identified several FDA-approved drug candidates that reverse disrupted behaviors in zebrafish carrying mutations linked to autism. The team screened 774 drugs against zebrafish with mutations in two autism risk genes (SCN2A and DYRK1A) and published their findings in the Proceedings of the National Academy of Sciences. What the Study Found. The Yale team created a database of 520 FDA-approved drugs and their effects on basic behaviors in zebrafish larvae. They then tested how these drugs affected zebrafish carrying mutations in SCN2A and DYRK1A, two genes strongly associated with autism spectrum disorder in humans. Levocarnitine emerged as a top candidate. This compound, which transports fatty acids into mitochondria for energy production, reversed dysregulated sleep and sensory processing behaviors in zebrafish with both gene mutations. According to the study, levocarnitine also corrected disrupted lipid metabolism and abnormal brain activity patterns in the zebrafish models. The researchers identified additional drug candidates specific to each gene mutation. Estropipate, an estrogen receptor agonist, suppressed behaviors linked to SCN2A mutations. Paclitaxel, a microtubule inhibitor already used in cancer treatment, showed promise for DYRK1A-related behaviors. Why This Matters for Families. Drug development timelines for autism treatments typically span decades. By screening FDA-approved drugs that have already cleared safety trials, researchers can potentially accelerate the path to clinical testing in humans. If a drug is already approved for another condition, doctors may prescribe it off-label while formal autism trials proceed. The focus on specific genetic mutations means families who...

Your child's neurologist just told you the seizures are medication resistant. You've tried three anticonvulsants. Maybe four. Each one came with side effects, and none of them worked well enough. Now you're hearing about dietary therapy from other parents online, and you need to know what the evidence shows. The ketogenic diet isn't alternative medicine. It's an evidence-based neurological intervention that's been used for drug-resistant epilepsy since the 1920s. About 20 to 30 percent of children with epilepsy don't respond adequately to medications. For many of these families, dietary therapy becomes the next conversation with their neurologist. Here's what you need to know about ketogenic and modified Atkins diets for childhood epilepsy, including how they work, what the research shows, and what families face when they commit to these protocols. How Dietary Therapy Works for Seizures. The ketogenic diet shifts your child's brain from running primarily on glucose to running on ketones. When carbohydrate intake is drastically restricted, the liver converts fat into ketone bodies. The brain uses these ketones for energy instead of glucose. This metabolic shift appears to reduce seizure activity through multiple mechanisms. Ketones stabilize neuronal membranes, modulate neurotransmitter function, and reduce oxidative stress in brain tissue. The exact mechanisms aren't fully understood, but the clinical effect is well documented: many children who don't respond to medications experience significant seizure reduction on a ketogenic diet. The classical ketogenic diet uses a 3:1 or 4:1 ratio of fat to combined protein and carbohydrates by weight. That's extremely high...

Guide to ketogenic and modified Atkins diets for drug-resistant childhood epilepsy, including how they work and what to expect.

Dietary Therapy for Epilepsy: A Parent's Guide to Ketogenic and Modified Atkins Diets

Your child's neurologist just told you the seizures are medication resistant. You've tried three anticonvulsants. Maybe four. Each one came with side effects, and none of them worked well enough. Now you're hearing about dietary therapy from other parents online, and you need to know what the evidence shows. The ketogenic diet isn't alternative medicine. It's an evidence-based neurological intervention that's been used for drug-resistant epilepsy since the 1920s. About 20 to 30 percent of children with epilepsy don't respond adequately to medications. For many of these families, dietary therapy becomes the next conversation with their neurologist. Here's what you need to know about ketogenic and modified Atkins diets for childhood epilepsy, including how they work, what the research shows, and what families face when they commit to these protocols. How Dietary Therapy Works for Seizures. The ketogenic diet shifts your child's brain from running primarily on glucose to running on ketones. When carbohydrate intake is drastically restricted, the liver converts fat into ketone bodies. The brain uses these ketones for energy instead of glucose. This metabolic shift appears to reduce seizure activity through multiple mechanisms. Ketones stabilize neuronal membranes, modulate neurotransmitter function, and reduce oxidative stress in brain tissue. The exact mechanisms aren't fully understood, but the clinical effect is well documented: many children who don't respond to medications experience significant seizure reduction on a ketogenic diet. The classical ketogenic diet uses a 3:1 or 4:1 ratio of fat to combined protein and carbohydrates by weight. That's extremely high...

The FDA approved Auvelity (dextromethorphan HBr and bupropion HCl) on April 30, 2026, to treat agitation associated with dementia due to Alzheimer's disease in adults. This is the first FDA-approved treatment for Alzheimer's agitation that isn't an antipsychotic. For families caring for adults with Down syndrome, this matters. Adults with Down syndrome face a 90% or higher lifetime risk of developing Alzheimer's disease, often in their 40s and 50s, decades earlier than typical onset. About 30% of people with Down syndrome in their 50s and 50% in their 60s develop Alzheimer's dementia. Agitation is one of the most challenging symptoms for families to manage at home. What Changed. Until this approval, the only FDA-approved medication for Alzheimer's agitation was brexpiprazole (Rexulti), an antipsychotic that carries a boxed warning for increased mortality risk in elderly patients with dementia-related psychosis. Many families and providers have been reluctant to use antipsychotics due to these safety concerns and side effects like sedation, motor problems, and metabolic changes. Auvelity works differently. It targets NMDA and sigma-1 receptors through its dextromethorphan component. Bupropion blocks an enzyme that breaks down dextromethorphan, keeping levels stable in the bloodstream. The exact mechanism for reducing agitation isn't fully understood, but the drug doesn't work through antipsychotic pathways. The Evidence. The FDA approval was based on four Phase 3 clinical trials involving adults with Alzheimer's disease and agitation. In the ACCORD-2 study, patients who continued taking Auvelity had a 3.6-fold lower risk of agitation relapse compared to those switched to placebo....

FDA approved Auvelity as the first non-antipsychotic treatment for Alzheimer's agitation, offering a new option for Down syndrome families.

FDA Approves First Non-Antipsychotic Drug for Alzheimer's Agitation. What Families Caring for Adults With Down Syndrome Need to Know.

The FDA approved Auvelity (dextromethorphan HBr and bupropion HCl) on April 30, 2026, to treat agitation associated with dementia due to Alzheimer's disease in adults. This is the first FDA-approved treatment for Alzheimer's agitation that isn't an antipsychotic. For families caring for adults with Down syndrome, this matters. Adults with Down syndrome face a 90% or higher lifetime risk of developing Alzheimer's disease, often in their 40s and 50s, decades earlier than typical onset. About 30% of people with Down syndrome in their 50s and 50% in their 60s develop Alzheimer's dementia. Agitation is one of the most challenging symptoms for families to manage at home. What Changed. Until this approval, the only FDA-approved medication for Alzheimer's agitation was brexpiprazole (Rexulti), an antipsychotic that carries a boxed warning for increased mortality risk in elderly patients with dementia-related psychosis. Many families and providers have been reluctant to use antipsychotics due to these safety concerns and side effects like sedation, motor problems, and metabolic changes. Auvelity works differently. It targets NMDA and sigma-1 receptors through its dextromethorphan component. Bupropion blocks an enzyme that breaks down dextromethorphan, keeping levels stable in the bloodstream. The exact mechanism for reducing agitation isn't fully understood, but the drug doesn't work through antipsychotic pathways. The Evidence. The FDA approval was based on four Phase 3 clinical trials involving adults with Alzheimer's disease and agitation. In the ACCORD-2 study, patients who continued taking Auvelity had a 3.6-fold lower risk of agitation relapse compared to those switched to placebo....

You're already logged in! If you've forgotten your password and would like to reset it, <a href="/logout/?redirect=/forgot-password/" alt="Logout page link" title="Logout page link">log out</a> first.

Forgot Password

Login

Zippedy Zap, You're Out!

Poof! You're Logged Out!

Logged Out and Ready to Go!

See You Later, Friend!

Bye for Now!

Farewell, Buddy!

Adios, Amigo!

Until Next Time!

So Long, Friend!

Ciao, Buddy!

Bon Voyage, Friend!

Goodbye for Now!

Hasta Luego, Amigo!

Catch You Later!

See You Soon!

Farewell for Now!

Bye-Bye, Friend!

Until We Meet Again!

Logout

Let's give you a brand new password. Please fill in the boxes below with your details. 📋✏️

The reset ID you provided is invalid. Please check the link you used to get here and try again. To request a new reset link, please visit the <a href="/forgot-password/">forgot password page</a>. 🔄

Let's get your password reset. Please fill in the boxes below with your details. 📋✏️

Reset Password 🔑

Your password has been reset! You can now <a href="/login/" alt="Login page link" title="Login page link">log in</a> with your new password. 🔒

Aw, shucks! We're not quite ready for more friends to join in just yet. 😿But here's the good news! We have a special, sparkly waitlist made just for you! 🥳🎉All you have to do is hop over to <a href='/waitlist/' alt='Waitlist Page' title='Waitlist Page'>the waitlist</a> and sign up. We'll get everything ready and before you know it, you'll be part of our SpecialNeeds.com family!🌟🤗💕 We can't wait to see you soon, 😃

Let's get you signed up so you can join our family. Please fill in the boxes below with your details. 📋✏️

Sign Up

The link you clicked appears to have embarked on its own adventure. Double-check it and let's try again, explorer! 🧭

Just a few more details and your fantastic journey begins! 😊 Rest assured, your data is as safe as a treasure in a dragon's den! 🐉🔒

Checkout

Title

Contact Listing Owner 🗣️

Looks like you need to join our fantastic community to contact the owner. Sign up now and dive into the adventure! 🎉

Whoa, There! 🖐️

This magical form lets you send an initial message to the listing owner. Just jot down a snappy topic (50 characters or less) and your message. Let's get the conversation rolling! 💌

Step right up! 🎪

Find local special needs events near you.

Events

Frequently Asked Questions

Discover the inspiring stories and experiences of our users who have found invaluable resources, support, and connections through SpecialNeeds.com.

Feedback

John Luthor

SpecialNeeds.com has been instrumental in helping me find the right resources for my child. The wealth of information and supportive community is invaluable.

Sarah Taylor

As a teacher, SpecialNeeds.com is my go-to website for understanding my students' diverse needs. The strategies and tips shared have been very helpful.

Alex Hales

The user interface of SpecialNeeds.com is very friendly and easy to navigate. It's a great platform with a lot of useful features for individuals with special needs.

David Warner

SpecialNeeds.com is a beacon of hope for parents like us. The online resources are fantastic and the supportive community is heartwarming.

Jessica Brown

The speech therapy resources on SpecialNeeds.com are top-notch. They've been incredibly helpful in my practice.

Michael Johnson

I've found so much support and understanding in the SpecialNeeds.com community. It has made all the difference for my family.

Emily Davis

SpecialNeeds.com is an invaluable tool in my classroom. The educational resources and community support are amazing.

Oliver Smith

SpecialNeeds.com offers practical and actionable occupational therapy strategies. It's a resource I use daily in my practice.

Sophia Miller

Navigating the world of special needs parenting can be challenging, but SpecialNeeds.com provides resources and a community that truly help.

User’s Feedback About SpecialNeeds.com

Guide your special needs-related business to reach its full potential. Here's the straightforward path to success

Begin by signing up for an account to join our community and initiate your journey.

Join Our Community

With your account set up, it's time to create your business listing. A well-crafted and engaging listing can attract more visitors.

Create Your Listing

Choose from our range of packages for your listing, including various features to suit your needs. We offer multiple options, including a free package.

Select Your Package

Once you submit your listing, our team will review it. Upon approval, your listing will be published on the site for public viewing.

Await Approval

Congratulations! Your listing is now live. You can view it on our site and begin attracting new visitors.

Your Listing is Live

How It Works

Discover our extensive directory featuring a wide range of special needs-related listings. Add your listing to join our growing community.

Explore Our Directory

Engage directly with users through our messaging feature. Manage all your conversations efficiently from your dashboard.

Connect and Communicate

Draw more visitors and grow your business. You have full control over your listing and can update or modify it as needed from your dashboard.

Enhance Your Listing

Supporting Your Business Growth

New Chat Received! 🎉

Enter your name

Pricing

Privacy Policy

Hi there! At SpecialNeeds.com, we care a lot about keeping your information private. We promise to do our best to keep your information safe and sound. This means we collect only the necessary information to provide you with the best possible experience on our site, and we take all the necessary steps to protect your information from unauthorized access, use, or disclosure.

1. Our Promise

When you join our site, we collect your email, display name, and password. We don't ever collect your location unless you tell us it's okay. Additionally, we use various analytics tools, which may collect other information like which pages you visit on our site, your IP address, and other data related to your use of our site. These tools help us understand how our site is used and enable us to improve your experience.

2. What We Collect

We collect information from you when you fill out forms on our site, like when you sign up. We also use cookies and Google Analytics to learn more about how you use our site. If you choose to enable the distance search feature, we'll collect your location information after getting your consent by clicking a button.

3. How We Collect It

We use your information to help you use our site and to make our site better for you. We also use it to see how people use our site, so we can make it better for everyone. Your location information, if you choose to share it, is used to help you find resources and services near you.

4. How We Use It

The majority of your information is kept confidential and is not shared with any third parties outside of SpecialNeeds.com. However, for users interacting with our directory listings (such as camps, schools, etc.), we may share aggregated and anonymized analytics data with the owners of these listings. This data may include metrics like the number of page views, time spent on the site, and other related usage statistics. It's important to note that this shared data will not include any personally identifiable information and is solely used to provide insights to our paid listing owners.

5. Who We Share It With

We use some fancy tech stuff to keep your information safe, like HTTPS for secure browsing, bcrypt to keep your password safe, and encryption to keep your location safe if you choose to share it with us. We also store your encrypted location information (if provided) in your browser's local storage and not on our servers, to add an extra layer of security.

6. How We Keep It Safe

You can change your email and password whenever you want. You can't change your display name once it's set, though. If you want to delete your account, you can do that, too. And remember, you can always tell us to stop using your location info by revoking your consent.

7. Changing or Deleting Your Info

Our site isn't made for kids under 13. We don't collect information from anyone under 13, and if we become aware of any such information, we will take steps to delete it.

8. Kids Under 13

Our site is made for people in the U.S. Even though we collect some information from people outside the U.S. through Google Analytics, our website is not targeted at them, and we do not use their information for anything other than Google Analytics.

9. People Outside the U.S.

Sometimes we might need to change this policy. If we do, we'll send you an email, and we'll put a notice on our site and on our social media accounts, if we have any. Please keep checking so you always know our latest policy.

10. Changes to This Policy

Remember, we're here to help. If you have any questions about this privacy policy, just ask!

Privacy Policy for SpecialNeeds.com

Terms and Conditions

Terms and Conditions for SpecialNeeds.com

Hi there! Welcome to SpecialNeeds.com. We're a website that helps people learn about special needs resources, like camps, schools, and therapists. We also share articles and news about special needs topics. But before you start exploring, we need you to understand and agree to our rules.

1. Welcome to Our Site!

Our site is primarily made for people who are 13 years or older. However, individuals under the age of 13 may access the content on our site under the supervision of a parent or legal guardian. While they cannot register for an account, they are welcome to read and learn from the information available with appropriate guidance.

2. Who Can Use Our Site

We want everyone to have a good time here, so we have some rules. You can't use our site to do anything illegal, to bother other people, to share spam, or to post mean or offensive things. And please, don't share anything that belongs to someone else without their permission.

3. Our Rules

Users can add items to our directory, but we'll need to say okay first. We use a smart computer program to check if anything mean or offensive gets posted. And we'll take down anything that's not okay right away.

4. Adding to Our Directory

If you break any of our rules, we might have to stop your account. This means you won't be able to use our site anymore. We don't want to do this, but sometimes we have to.

5. Accounts and What Can Happen

We do our best to share good, helpful information. But we can't promise that everything is perfect or right for you. We're not doctors, and we don't give medical advice. Always check with your own doctor or do your own research.

6. What We Can Promise

If we have a disagreement, we'd like to work it out with you. But if we can't, then we'll have to ask a neutral person or group (this is called an arbitrator) to help us solve it.

7. What Happens If We Disagree

Sometimes we might need to change these rules. If we do, we'll send you an email, and post on our social media accounts, if we have any. Please keep checking so you always know our latest rules.

8. Changes to These Rules

Remember, we're here to help. If you have any questions about these terms and conditions, just ask!

At SpecialNeeds.com, we strive to foster a community of trust and reliability. One significant way we ensure this trust is through our Verified Badge. You may have spotted this little checkmark symbol on our platform. But do you know what it signifies? Allow us to pull back the curtain on this important aspect of our platform. The Verified Badge isn't merely decorative - it's a symbol of authenticity, accuracy, and connection. When you see this badge associated with a company, you can rest assured that the company has been thoroughly vetted and is confirmed to be genuine. But how do we ascertain this genuineness? The process is both rigorous and meticulous. To earn the Verified Badge, a company representative or a SpecialNeeds.com staff member must first register with us and provide evidence of their affiliation with the company. This is typically in the form of a business email address. However, the badge doesn't just signify affiliation. It's also a testament to accuracy. The representative or our staff member is responsible for verifying all information associated with the company - from contact details to rates and features. Only when every piece of information has been scrutinized and confirmed do we award the coveted Verified Badge. Maintaining the Verified Badge isn't a one-time effort - it requires an annual renewal. Each year, company representatives are required to reaffirm their details and reverify their information. This ensures that the data associated with Verified Badge holders remains up-to-date and accurate. If the information isn't refreshed yearly, the Verified Badge status lapses. This renewal requirement serves as an ongoing commitment to accuracy, reinforcing our dedication to providing reliable, current information for our community. But why is this badge important? Why should you, as a user of our platform, trust it? The answer is simple. The Verified Badge is your compass on SpecialNeeds.com, guiding you with the assurance of truth and reliability. This badge is our commitment to you. It's our guarantee that the information you're viewing has been checked for accuracy and confirmed for authenticity. Whenever you see this badge, you know you're looking at a company that has been meticulously verified. That's our promise to you. So, as you explore the vibrant world of special needs-related businesses on SpecialNeeds.com, remember to look out for our Verified Badge. It's more than a symbol - it's the mark of trust you can rely on.

Verified Badge

Verified Listing: Last verified <lastVerified>. Click to learn more.

Special Needs
Articles

CRISPR Gene Therapy for Rare Pediatric Disorders: What Families Need to Know

IEP Advocacy for Children with Rare Disorders: When No One Has Done This Before

Tariffs Are Raising the Cost of Wheelchairs, AAC Devices, and Medications — What Families Can Do

Obesity Linked to Autism

Yale Researchers Used Zebrafish to Find Drug Candidates That Could Help Children with Autism

Dietary Therapy for Epilepsy: A Parent's Guide to Ketogenic and Modified Atkins Diets

FDA Approves First Non-Antipsychotic Drug for Alzheimer's Agitation. What Families Caring for Adults With Down Syndrome Need to Know.

Find Providers Near You

Special Needs Articles

CRISPR Gene Therapy for Rare Pediatric Disorders: What Families Need to Know

IEP Advocacy for Children with Rare Disorders: When No One Has Done This Before

Tariffs Are Raising the Cost of Wheelchairs, AAC Devices, and Medications — What Families Can Do

Obesity Linked to Autism

Yale Researchers Used Zebrafish to Find Drug Candidates That Could Help Children with Autism

Dietary Therapy for Epilepsy: A Parent's Guide to Ketogenic and Modified Atkins Diets

FDA Approves First Non-Antipsychotic Drug for Alzheimer's Agitation. What Families Caring for Adults With Down Syndrome Need to Know.

Find Providers Near You

Special Needs
Articles